Tuesday, 02 January 2024 12:17 GMT
عربي


               US          Europe          Arab          Asia          Africa    
|      Politics          Economy     Oil&Energy         
                 Entertainment          Sport
Netramarkholdings Inc.

Netramarkholdings Inc.


2026-03-19 10:06:08
(MENAFN- Baystreet) 10:01 AM EST - NetraMarkHoldings Inc.: Announced new findings illustrating the ability of its proprietary explainable AI platform, NetraAI, to uncover clinically meaningful responder subgroups within the landmark Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial. NetraMarkHoldings Inc. shares T are trading unchanged at $1.00.

MENAFN19032026000212011056ID1110883720



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Tags

Label

Comments

No comment

Category

Date
Search